This site uses cookies in order to function properly and to allow us to improve our service.
By using this site you consent to the use of cookies. Find out more HERE

CLOSE [X]
Subscriber login Close [x]
remember me
You are not logged in.

GOOD HALF-YEARS FOR SOUTHCORP AND DIAGEO

Published:  23 July, 2008

Two of the world's largest drinks companies, Diageo and Southcorp, have both reported improved performances in their half-year trading statements, although neither feat was without difficulties. At Diageo, a 6% profit growth for the six months to 31 December 2003 was marred by the continuing decline of the RTD sector. Though Smirnoff Ice reported a rise in market share in the sector from 25.6% to 28.4%, sales volumes of the brand fell by 12%. Bell's was another struggler. The brand remains the number one blended Scotch whisky in Great Britain, but volumes declined by 3%. Better news came from the company's wine division, Percy Fox, which put in a strong performance, with Blossom Hill taking over as the bestselling wine brand in the UK off-trade, and Piat d'Or continuing its renaissance, with sales (in excess of 1 million cases) at their highest in the brand's 24-year history. Other strong performers in the Diageo portfolio included: Smirnoff (up 9% in volume); Baileys (up 7%); Gordon's (up 7%); and Pimms (up 34%). In Sydney, Southcorp chief executive John Ballard reported a net profit of A$40.5 million for the six months to December 2003, a notable improvement on the A$5.7 million made by the company in the six months to December 2002. The company was especially pleased by the return to profit of its British and European divisions, which showed a rise in EBITA (earnings before interest, tax and amortisation) from A$1.6 million to A$13.2 million. Ballard's stated intention of improving margins seemed to be paying off in Britain and Europe and Australasia, with average sales revenue per case rising by 10% and 16% respectively, and the company's cost-cutting drive, Project Veraison', had saved A$23 million. Sales revenue per case declined by 2.6% in the US. Total sales revenues were down, too, dropping by 17.4% to A$513.3 million, due to lower case-volumes and the effects of the strong Australian dollar, which cut revenue by A$68.4 million.

Keywords: